Prevention is the most important measure in the fight against tumor diseases. Every fifth tumor develops due to a hereditary predisposition. Knowing predispositions and being able to initiate appropriate early detection examinations is a central component in the prevention of metastatic and late-detected disease progression. Since its foundation in 2009, CeGaT has been specializing in […]
https://www.cegat.de/web/wp-content/uploads/2018/02/KeyVisual-CAN-BW.jpg5601920Nora Zellerhttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.pngNora Zeller2020-07-29 13:28:292020-07-29 13:34:46Update of the Panel for Hereditary Tumor Diseases (CAN)
CeGaT has updated its Panels for Blood Disorders (BLD) and Immune Disorders (PID) according to the latest state of scientific knowledge. The diagnostic sensitivity increased even further. As part of the updates, the composition and structure of the panels have been revised to more clearly differentiate the disease patterns covered. This provides physicians with optimized […]
https://www.cegat.de/web/wp-content/uploads/2018/08/KeyVisual-BLD-Color-RGB.jpg5601920Nora Zellerhttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.pngNora Zeller2020-07-01 17:15:082020-07-30 09:29:11Update of the Panels for Blood Disorders and Immune Disorders
Our mission is to support scientists like you to accomplish your project, regardless of its scope. With rapid advancements in sequencing technology and capacity, we believe that genome sequencing as the gold standard for genetic analyses should be available to every scientist committed to the wide field of biology. We are your first choice genome […]
Tübingen, May 27, 2020: CeGaT GmbH started corona antibody testing May 11. In light of great public interest, CeGaT publishes statistics on the test results on its website. The statistics will be updated every Monday in the early afternoon by adding the data of the previous week. 8.8 percent of the 6,776 people tested have […]
Since May 11, 2020, CeGaT offers a CE certified corona antibody test. This test determines whether a person has antibodies against the coronavirus SARS-CoV-2. People who have antibodies are assumed to have undergone a coronavirus infection and are highly likely to be immune. The collection tubes required for the test can be ordered via the […]
https://www.cegat.de/web/wp-content/uploads/2020/04/Corona_Keyvisual_1920x1080px_WEB.jpg10801920Nora Zellerhttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim.pngNora Zeller2020-05-12 10:01:262020-07-29 16:10:10CeGaT Offers Corona Antibody Test
Update of the Panel for Hereditary Tumor Diseases (CAN)
/in Diagnostic Panels /by Nora ZellerPrevention is the most important measure in the fight against tumor diseases. Every fifth tumor develops due to a hereditary predisposition. Knowing predispositions and being able to initiate appropriate early detection examinations is a central component in the prevention of metastatic and late-detected disease progression. Since its foundation in 2009, CeGaT has been specializing in […]
Update of the Panels for Blood Disorders and Immune Disorders
/in Diagnostic Panels /by Nora ZellerCeGaT has updated its Panels for Blood Disorders (BLD) and Immune Disorders (PID) according to the latest state of scientific knowledge. The diagnostic sensitivity increased even further. As part of the updates, the composition and structure of the panels have been revised to more clearly differentiate the disease patterns covered. This provides physicians with optimized […]
Your Science. Our Sequencers.
/in Research /by Nora ZellerOur mission is to support scientists like you to accomplish your project, regardless of its scope. With rapid advancements in sequencing technology and capacity, we believe that genome sequencing as the gold standard for genetic analyses should be available to every scientist committed to the wide field of biology. We are your first choice genome […]
CeGaT Presents Results of Corona Antibody Tests
/in About CeGaT /by woltersTübingen, May 27, 2020: CeGaT GmbH started corona antibody testing May 11. In light of great public interest, CeGaT publishes statistics on the test results on its website. The statistics will be updated every Monday in the early afternoon by adding the data of the previous week. 8.8 percent of the 6,776 people tested have […]
CeGaT Offers Corona Antibody Test
/in Diagnostics /by Nora ZellerSince May 11, 2020, CeGaT offers a CE certified corona antibody test. This test determines whether a person has antibodies against the coronavirus SARS-CoV-2. People who have antibodies are assumed to have undergone a coronavirus infection and are highly likely to be immune. The collection tubes required for the test can be ordered via the […]